跳至主要内容
临床试验/NCT02285218
NCT02285218Unknown不适用

Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD

Yonsei University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2014年4月最近更新:
适应症

试验速览

阶段
不适用
入组人数
200
试验地点
1
主要终点
new adipokines

研究概览

简要总结

To investigate the predictive roles of adipokines and hepatokines to detect non-alcoholic fatty liver disease (NAFLD), diabetes, or dyslipidmia.

To examine the association or effects of clinical and biochemical factors (lab results and medication, etc.) on serum levels of adipokines and hepatokines in certain subjects with non-alcoholic fatty liver disease (NAFLD), diabetes, or dyslipidmia.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • dyslipidemia
  • serum triglyceride≥150mg/dl, or taking medication to lower triglyceride levels (e.g. fibrates, niacin, omega-3, etc.) or
  • serum LDL-C≥100mg/dl, or taking medication to lower LDL-C levels (e.g. statin, ezetimibe, etc.)
  • type 2 diabetes
  • defined according to the ADA guideline (DM definition) or
  • taking any anti-diabetic medications
  • non-alcoholic fatty liver disease (NAFLD)
  • diagnosed as having fatty liver by ultrasonogram or
  • diagnosed as having fatty liver by transient elastogram (Fibroscan) or
  • diagnosed as having fatty liver by abdomina CT scan
  • Normal control
  • should not be included in other groups as above and
  • not taking any medication related to diabetes and dyslipidemia and
  • BMI <25kg/m2

排除标准

  • subjects who refused to agree with informed consents
  • subjects with organ-transplantation
  • serum creatinine ≥1.5mg/dl
  • pregnant women
  • liver cancer or pancreatic cancer
  • subjects with chronic hepatitis B or C virus infection
  • for NAFLD group, subjects with excessive alcohol consumption (men: ≥210g of alcohol per week, women: ≥140g of alcohol per week)

结局指标

主要结局

new adipokines

时间窗: To 8h fasting blood sample

several candidate adipokines and hepatokines to predict diseases will be measured using ELISA

new hepatokines

时间窗: To 8h fasting blood sample

several candidate adipokines and hepatokines to predict diseases will be measured using ELISA

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验